SCHEMBL9669255

SCHEMBL9669255

O=[C]c1cc([N+](=O)[O-])cc2ccccc12

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.62
TDP1 Q9NUW8 2/20 0.62
CYP3A4 P08684 1/20 0.50
ALDH1A1 P00352 4/20 0.44
CASP6 P55212 2/20 0.44
PTPN1 P18031 1/20 0.42
MEN1 O00255 3/20 0.42
KMT2A Q03164 3/20 0.42
RAB9A P51151 2/20 0.42
ALOX5 P09917 3/20 0.41
PTGES O14684 1/20 0.41
LMNA P02545 2/20 0.41
HPRT1 P00492 1/20 0.40
MAPT P10636 2/20 0.40
KDM4E B2RXH2 1/20 0.40
NPC1 O15118 1/20 0.40
PKM P14618 1/20 0.40
NFKB1 P19838 1/20 0.40
HTT P42858 1/20 0.40
NFKB2 Q00653 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4872767 0.81 TSHR (0.47) TSHRTDP1CYP3A4ALDH1A1MEN1
SCHEMBL57381 0.77 TDP1 (1.00) TSHRTDP1CYP3A4ALDH1A1CASP6
SCHEMBL29475186 0.77 TDP1 (1.00) TSHRTDP1CYP3A4ALDH1A1CASP6
SCHEMBL16652207 0.76 TDP1 (0.62) TSHRTDP1CYP3A4ALDH1A1CASP6
SCHEMBL1378334 0.75 TDP1 (0.66) TSHRTDP1CYP3A4ALDH1A1CASP6
SCHEMBL17599539 0.75 TSHR (0.66) TSHRTDP1CYP3A4ALDH1A1CASP6
Methane SCHEMBL28603558 0.75 TDP1 (0.96) TSHRTDP1CYP3A4ALDH1A1CASP6
SCHEMBL30065083 0.75 TSHR (0.66) TSHRTDP1CYP3A4ALDH1A1CASP6
SCHEMBL10688399 0.75 TSHR (0.66) TSHRTDP1CYP3A4ALDH1A1CASP6
SCHEMBL8688741 0.75 TDP1 (0.66) TSHRTDP1CYP3A4ALDH1A1CASP6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5155113-A Administering 5-fluorouracil and derivatives with pyridine and pyridone derivatives OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-10-13 US disclosed
EP-0180188-B1 A COMPOSITION FOR INCREASING THE ANTI-CANCER ACTIVITY OF AN ANTI-CANCER COMPOUND OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-04-15 EP disclosed
EP-0180188-A2 A composition for increasing the anti-cancer activity of an anti-cancer compound OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-05-07 EP disclosed